Leeward Financial Partners’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $602K | Hold |
51,650
| – | – | 0.19% | 61 |
|
|
2025
Q1 | $384K | Hold |
51,650
| – | – | 0.14% | 64 |
|
|
2024
Q4 | $310K | Hold |
51,650
| – | – | 0.11% | 72 |
|
|
2024
Q3 | $264K | Hold |
51,650
| – | – | 0.1% | 76 |
|
|
2024
Q2 | $187K | Hold |
51,650
| – | – | 0.08% | 84 |
|
|
2024
Q1 | $166K | Sell |
51,650
-2,447
| -5% | -$7.86K | 0.07% | 92 |
|
|
2023
Q4 | $265K | Hold |
54,097
| – | – | 0.13% | 74 |
|
|
2023
Q3 | $295K | Hold |
54,097
| – | – | 0.16% | 64 |
|
|
2023
Q2 | $363K | Hold |
54,097
| – | – | 0.21% | 64 |
|
|
2023
Q1 | $478K | Hold |
54,097
| – | – | 0.29% | 56 |
|
|
2022
Q4 | $413K | Sell |
54,097
-13,000
| -19% | -$99.3K | 0.29% | 57 |
|
|
2022
Q3 | $478K | Hold |
67,097
| – | – | 0.34% | 54 |
|
|
2022
Q2 | $543K | Sell |
67,097
-1,407
| -2% | -$11.4K | 0.37% | 53 |
|
|
2022
Q1 | $951K | Sell |
68,504
-2,472
| -3% | -$34.3K | 0.59% | 47 |
|
|
2021
Q4 | $1.99M | Buy |
+70,976
| New | +$1.99M | 1.25% | 31 |
|